Credence BtK
Credence BtK Sirolimus Eluting BioResorbable Peripheral Scaffold System
Peripheral StentsMeril Life Sciences
Indigenously developed peripheral BtK technology featuring sirolimus eluting bioresorbable scaffold system for peripheral vessel treatment with rapid exchange delivery system
Product overview
Indigenously developed peripheral BtK technology featuring sirolimus eluting bioresorbable scaffold system for peripheral vessel treatment with rapid exchange delivery system
Technical specifications
| scaffold material | BioResorbable PLLA (Poly L-lactide) |
| scaffold strut thickness | 100 μm |
| scaffold diameters | 2.50, 3.00, 3.50 mm |
| scaffold lengths | 32, 40 mm |
| drug | Sirolimus |
| drug dose | 1.25 μg / mm2 |
| polymer | Bioresorbable PDLLA (Poly D, L-lactide) |
| delivery system | Rapid Exchange |
| nominal pressure | 9 atm |
| rated burst pressure | 16 atm |
| balloon overhang | 1 mm |
| shaft outer diameter | 6 F (Min. I.D 0.070" / 1.8 mm) |
| radiopaque markers | 2 - Platinum / Iridium |
| catheter length | 142 cm |
| sheath compatibility | 6 F |
| guidewire compatibility | 0.014" (0.36 mm) |
Clinical scope
Procedures
- • Peripheral Artery Disease Treatment
- • Below-the-Knee Revascularization
- • Critical Limb Ischemia Intervention
- • Infrapopliteal Angioplasty
Anatomical focus
- • Below-the-Knee (BtK) Arteries
- • Infrapopliteal Vessels
- • Tibial Arteries
- • Peroneal Arteries
Indications & use cases
BtK interventionsmall vessel diseasecritical limb ischemiadiabetic foottemporary scaffoldingbioresorbable technologysirolimus antiproliferativeperipheral arterial disease